Search Results
Metastatic Hormone Positive Breast Cancer | 2023 KU Breast Cancer Year in Review Conference
HER2 Low Breast Cancer A New Therapeutic Subtype | 2023 KU Breast Cancer Year in Review Conference
Adjuvant Therapy | 2023 KU Breast Cancer Year in Review Conference
Historical Perspective on HR+/HER2- Breast Cancer: 2023 KU Breast Cancer Year in Review
2022 KU Post San Antonio Review | Metastatic HER2 Positive Breast Cancer: Novel Treatment Approaches
2022 KU Post San Antonio Review | Early-Stage Hormone + Breast Cancer: Optimizing Systemic Therapy
Antibody-Drug Conjugates for HER2-Low Disease: 2023 KU Breast Cancer Year in Review
Updates in Metastatic Breast Cancer: 2023 West Oncology
Lightning Updates | 2023 Best of Breast Conference
Sequencing Treatment Options in HER2 Positive Breast Cancer: 2023 Best of Breast Conference
Hot Topics for Case Discussion in Breast Cancer: 2023 KU Breast Cancer Year in Review
The use of frontline CDK4/6 inhibitors + endocrine therapy in metastatic breast cancer
